AI Driven Drug Discovery Summit 2023 | Kisaco Research | 5 December 2023 | Sheraton Boston Hotel, 39 Dalton St, Boston, MA 02199, USA

Why You Should Attend?

• Engage with leading pharma and biotech companies as they discuss the current state of AI-assisted drug discovery and explain how they are adjusting existing processes to drive decisions on AI insights
• Discuss how AI can be leveraged to support multi-omic data integration
• Understand how recent advances in AI/ML are improving the accuracy of therapeutic target identification
• Discover how AI is accelerating drug safety assessments and how researchers are augmenting toxicity predictions through in silico ADMET models
• Connect with industry leaders using AI/ML to aid drug repositioning efforts for rare disease and learn from SARS-CoV-2 drug repurposing efforts
• Upskill decision makers and users on AI methodologies and limitations to avoid black box mistrust
• Identify new AI-native partners and learn to better manage existing partnerships to further integrate AI processes across functions

2023 Speakers

Abraham Heifets
Co-Founder & CEO, Atomwise

Petrina Kamya
Global Head of AI Platforms, VP Insilico Medicine President, Insilico Medicine Canada Inc.

Alex Gaither
Vice President and Head of Oncology, Exscientia

Elena Diaz Cecilia
Senior Director, External Innovation, Janssen R&D

Stephen MacKinnon
Vice President of Digital Chemistry, Recursion Pharma

Venkat Mattela
Founder and CEO, Ceremorphic

Daniel Jamieson
CEO, Biorelate

Andreas Holm Mattsson
Chief AI Officer & Founder, Evaxion

Byungchan Kim
Executive Director in Drug Discovery, XTALPI

Ari Allyn-Feuer
Director AI Product, GSK

Dane Corneil
AI Lead for Target-ID, Benevolentai

Clement Charelain
Head Human Genetics and Genomics, Sanofi

Claire Zhao
Associate Director of AI/ML & Quantitative and Digital Sciences, PFIZER

Neil Inala
Chief Executive Officer, Nobias Therapeutics

Nick Nystrom
Chief Technology Officer, Peptilogics

Diana Miszczuk
Director External Partnerships, Digital & Research Intelligence, Novo Nordisk

Aaron Mackey
VP Head of AI and ML, Sonata

Lingling Shen
Associate Director Discovery Sciences, Novartis

Chris Tame
VP Head of Drug Discovery, Celeris Therapeutics

Ed Addison
Executive Chairman & Acting CEO, Cloud Pharmaceuticals

Martin Gershon
Managing Partner & CIO, Endeavor Life Sciences Venture Funds

Andrew Hadin
Partner, Bessemer Venture Partners

Liz Schwarzbach
Chief Business Officer, BigHat Biosciences

Colm O'Dushlaine
Head of Statistical Genetics, Insitro

Simon Beaulah
SVP Precision Drug Repositioning, Precisionlife

Arvind Rao
Associate Professor Computational Medicine & Bioinformatics, University of Michigan

Gary An
Professor of Surgery and Board Member Complexity in Acute Illness, University of Vermont

Alla Bushoy
Engineering Team Lead, AstraZeneca

Max Liu
Senior Software Engineer - Early Science, AstraZeneca

Jian Fang
Senior Expert II Data Science Discovery Sciences, Novartis

Hunter Elliot
Principal Machine Learning Scientist, BigHat Biosciences

Zachary Webel
Data Scientist and Applied Mathematician, FDA

Sourav Bandyopadhyay
Chief Technology Officer, Rezo Therapeutics

Matthias Alder
Chief Executive Officer, Gain Therapeutics

Lu Zhang
Founder & Managing Partner, Fusion Fund

2023 Sponsor & Partners

PLATINUM PARTNER:
• Ceremorphic

GOLD PARTNERS:
• Biorelate
• XtalPi

SILVER SPONSOR:
• Jubilant Biosys